对「探讨选择性盆腔放疗在高危和极高危非转移性前列腺癌患者中的作用」评论的回应
Response to the Comment on "Examining the role of elective pelvic radiotherapy in patients diagnosed with high- and very high-risk non-metastatic prostate cancer".
PubMed 文献 · Clin Transl Radiat Oncol · 2025-09-30
本文是对前述评论的回应,感谢评论作者对原文的关注,并指出该领域复杂且难以研究,但能激发高水平学术讨论,作者乐于回应评论中提出的问题。
要点
- 本文为对评论的回应,未提供新的研究数据或结论
- 作者感谢评论作者对原文的关注与学术讨论
- 作者表示乐于回应评论中提出的问题
核心结论
- 作者感谢评论作者对原文的关注,并乐于回应其提出的问题。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
First of all, we would like to sincerely thank the colleagues who authored the commentary on our article. It is encouraging to see that this complex and difficult-to-study field stimulates high-level academic discourse. Precisely for this reason, we are pleased to address the questions they have raised.
来源:Clin Transl Radiat Oncol,查看原文。版权归原作者所有。
引用
- Nahaji I, Kocsis ZS, Ágoston P, et al. Response to the Comment on "Examining the role of elective pelvic radiotherapy in patients diagnosed with high- and very high-risk non-metastatic prostate cancer". Clin Transl Radiat Oncol. 2025. PMID: 41080984. doi:10.1016/j.ctro.2025.101055
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。